Browse By Cancer Type Result Page of OvirusTdb

The total number of records retrieved from this search are 58. Click on ID to see further detail.
IDVirus nameVirus strainVirus genome typeVirus familyVirus genome modificationVirus aloneVirus in combination with drug/radiationImmune gene insertion in viral genomeSource of cell lineOrigin of cell lineCell lineConcentration of cell lineIn-vitro toxicityAssayIn-vitro virus concentrationIn-vitro resultModel organismIn-vivo virus concentrationIn-vivo toxicityIn-vivo resultMode of deliveryPathway inducedImmunogenic effectClinical trialPMID
OV_2977Reoviruswild typeRNAReoviridaeNoneYesNoNoATCCHuman neck and squamous carcinoma cell lineSCC-97.68E+3 cells per wellNAAlamar blue assay2.4 × 10⁸ pfu33.2 +/- 9.9% cell viable after 96 hoursNoNoNA No responseNANANANA25890191
OV_2978Reoviruswild typeRNAReoviridaeNoneYesNoNoATCCHuman neck and squamous carcinoma cell lineSCC-257.68E+3 cells per wellNAAlamar blue assay2.4 × 10⁸ pfu54.6 +/- 21.5% cell viable after 96 hoursNoNoNA No responseNANANANA25890191
OV_2979Reoviruswild typeRNAReoviridaeNoneYesNoNoATCCHuman neck and squamous carcinoma cell lineUM-SCC-387.68E+3 cells per wellNAAlamar blue assay2.4 × 10⁸ pfu83.9 +/- 16.3% cell viable after 96 hoursNoNoNA No responseNANANANA25890191
OV_2980Reoviruswild typeRNAReoviridaeNoneYesNoNoATCCHuman neck and squamous carcinoma cell lineUM-SCC-477.68E+3 cells per wellNAAlamar blue assay2.4 × 10⁸ pfu97.2 +/- 4.7% cell viable after 96 hoursNoNoNA No responseNANANANA25890191
OV_2981Reoviruswild typeRNAReoviridaeNoneYesNoNoATCCHuman neck and squamous carcinoma cell lineUM-SCC-1047.68E+3 cells per wellNAAlamar blue assay2.4 × 10⁸ pfu82.3 +/- 6.5% cell viable after 96 hoursNoNoNA No responseNANANANA25890191
OV_3066Vaccinia virusDeltaJ2R/FCU1 VACVDNAPoxviridaeDeletion of J2R gene and insertion of gene FCU1YesNoNoCantren Antoine- lacassagne, FranceHuman head and neck squamous cell carcinoma cell lineCAL333.0E+5 cells per wellNATrypan blue assay10⁻⁴ MOI18% cell viabilityNoNoNA No responseNANANANA31011628
OV_3067Vaccinia virusDeltaJ2R/FCU1 VACVDNAPoxviridaeDeletion of J2R gene and insertion of gene FCU1YesNoNoCantren Antoine- lacassagne, FranceHuman head and neck squamous cell carcinoma cell lineCAL333.0E+5 cells per wellNATrypan blue assay10⁻³ MOI1% cell viabilityNoNoNA No responseNANANANA31011628
OV_3068Vaccinia virusDeltaJ2R/FCU1 VACVDNAPoxviridaeDeletion of J2R gene and insertion of gene FCU1YesNoNoCantren Antoine- lacassagne, FranceHuman head and neck squamous cell carcinoma cell lineCAL333.0E+5 cells per wellNATrypan blue assay10⁻² MOI100% cell deathNoNoNA No responseNANANANA31011628
OV_3096Vaccinia virusDeltaJ2R-I4L/FCU1 VACV (TG6002)DNAPoxviridaeDeletion of J2R and I4L gene and insertion of gene FCU1YesNoNoCantren Antoine- lacassagne, FranceHuman head and neck squamous cell carcinoma cell lineCAL333.0E+5 cells per wellNATrypan blue assay10⁻⁴ MOI18% cell viabilityNoNoNA No responseNANANANA31011628
OV_3097Vaccinia virusDeltaJ2R-I4L/FCU1 VACV (TG6002)DNAPoxviridaeDeletion of J2R and I4L gene and insertion of gene FCU1YesNoNoCantren Antoine- lacassagne, FranceHuman head and neck squamous cell carcinoma cell lineCAL333.0E+5 cells per wellNATrypan blue assay10⁻³ MOI2% cell viabilityNoNoNA No responseNANANANA31011628
OV_3098Vaccinia virusDeltaJ2R-I4L/FCU1 VACV (TG6002)DNAPoxviridaeDeletion of J2R and I4L gene and insertion of gene FCU1YesNoNoCantren Antoine- lacassagne, FranceHuman head and neck squamous cell carcinoma cell lineCAL333.0E+5 cells per wellNATrypan blue assay10⁻² MOI100% cell deathNoNoNA No responseNANANANA31011628
OV_3115Vaccinia virusDeltaJ2R/FCU1 VACVDNAPoxviridaeDeletion of J2R gene and insertion of gene FCU1NoVirus strain in combination with 5-FC (200mg/kg)NoCantren Antoine- lacassagne, FranceHuman head and neck squamous cell carcinoma cell lineCAL33NANANANANABD62 mice xenograft for Lovo cell line1.0E+7 pfuNA Tumor volume decreases to below 100 mm after 50 daysIntravenousNANANA31011628
OV_3116Vaccinia virusDeltaJ2R-I4L/FCU1 VACV (TG6002)DNAPoxviridaeDeletion of J2R and I4L gene and insertion of gene FCU1NoVirus strain in combination with 5-FC (200mg/kg)NoCantren Antoine- lacassagne, FranceHuman head and neck squamous cell carcinoma cell lineCAL33NANANANANABD62 mice xenograft for Lovo cell line1.0E+7 pfuNA Tumor volume decreases to below 100 mm after 50 daysIntravenousNANANA31011628
OV_4401AdenovirusONYX-015DNAAdenoviridaeNoneYesNoNoSt. Joseph healthcare, LondonHuman head and neck squamous cell carcinomaHN-5aNANAStatistical method16.64+/- 1.4120% cancer cell deathNoNoNA No responseNAIncrease in apoptosis upto 25%NANA26429639
OV_4402AdenovirusONYX-015DNAAdenoviridaeNoneYesNoNoSt. Joseph healthcare, LondonHuman head and neck squamous cell carcinomaHN-5aNANAStatistical method57.46+/- 8.3750% cancer cell deathNoNoNA No responseNAIncrease in apoptosis upto 25%NANA26429639
OV_4403AdenovirusONYX-015DNAAdenoviridaeNoneYesNoNoSt. Joseph healthcare, LondonHuman head and neck squamous cell carcinomaHN-5aNANAStatistical method96.31+/- 10.7670% cancer cell deathNoNoNA No responseNAIncrease in apoptosis upto 25%NANA26429639
OV_4404AdenovirusONYX-015DNAAdenoviridaeNoneYesNoNoSt. Joseph healthcare, LondonHuman head and neck squamous cell carcinomaHN-5a/carbo-15aNANAStatistical method16.56+/- 2.7820% cancer cell deathNoNoNA No responseNAIncrease in apoptosis upto 25%NANA26429639
OV_4405AdenovirusONYX-015DNAAdenoviridaeNoneYesNoNoSt. Joseph healthcare, LondonHuman head and neck squamous cell carcinomaHN-5a/carbo-15aNANAStatistical method52.17+/- 9.6850% cancer cell deathNoNoNA No responseNAIncrease in apoptosis upto 25%NANA26429639
OV_4406AdenovirusONYX-015DNAAdenoviridaeNoneYesNoNoSt. Joseph healthcare, LondonHuman head and neck squamous cell carcinomaHN-5a/carbo-15aNANAStatistical method90.13+/- 14.4270% cancer cell deathNoNoNA No responseNAIncrease in apoptosis upto 25%NANA26429639
OV_4416AdenovirusONYX-015DNAAdenoviridaeNoneNoVirus in combination with melphalan (2.5 microgram)NoSt. Joseph healthcare, LondonHuman head and neck squamous cell carcinomaHN-5aNANAFlow cytometry20 pfu3% cancer cell death after day 3NoNoNA No responseNAIncrease in apoptosis upto 25%NANA26429639
OV_4417AdenovirusONYX-015DNAAdenoviridaeNoneNoVirus in combination with melphalan (5 microgram)NoSt. Joseph healthcare, LondonHuman head and neck squamous cell carcinomaHN-5aNANAFlow cytometry20 pfu6% cancer cell death after day 3NoNoNA No responseNAIncrease in apoptosis upto 25%NANA26429639
OV_4418AdenovirusONYX-015DNAAdenoviridaeNoneNoVirus in combination with melphalan (7.5 microgram)NoSt. Joseph healthcare, LondonHuman head and neck squamous cell carcinomaHN-5aNANAFlow cytometry20 pfu10% cancer cell death after day 3NoNoNA No responseNAIncrease in apoptosis upto 25%NANA26429639
OV_4419AdenovirusONYX-015DNAAdenoviridaeNoneNoVirus in combination with melphalan (2.5 microgram)NoSt. Joseph healthcare, LondonHuman head and neck squamous cell carcinomaHN-5aNANAFlow cytometry20 pfu3% cancer cell death after day 3NoNoNA No responseNAIncrease in apoptosis upto 25%NANA26429639
OV_4420AdenovirusONYX-015DNAAdenoviridaeNoneNoVirus in combination with melphalan (5 microgram)NoSt. Joseph healthcare, LondonHuman head and neck squamous cell carcinomaHN-5aNANAFlow cytometry20 pfu15% cancer cell death after day 3NoNoNA No responseNAIncrease in apoptosis upto 25%NANA26429639
OV_4421AdenovirusONYX-015DNAAdenoviridaeNoneNoVirus in combination with melphalan (7.5 microgram)NoSt. Joseph healthcare, LondonHuman head and neck squamous cell carcinomaHN-5aNANAFlow cytometry20 pfu25% cancer cell death after day 3NoNoNA No responseNAIncrease in apoptosis upto 25%NANA26429639
OV_4607AdenovirusAd5/3-CB016DNAAdenoviridaeMutation in delta E3 geneYesNoNoVU university medical centre, NetherlandHuman neck and squamous cell carcinoma cell line93VU147T3000 cells per wellNAMTT assay1 VP per cell100% cell viablity after 3 daysNoNoNA No responseNANANANA27086483
OV_4608AdenovirusAd5/3-CB016DNAAdenoviridaeMutation in delta E3 geneYesNoNoVU university medical centre, NetherlandHuman neck and squamous cell carcinoma cell line93VU147T3000 cells per wellNAMTT assay10 VP per cell100% cell viablity after 3 daysNoNoNA No responseNANANANA27086483
OV_4609AdenovirusAd5/3-CB016DNAAdenoviridaeMutation in delta E3 geneYesNoNoVU university medical centre, NetherlandHuman neck and squamous cell carcinoma cell line93VU147T3000 cells per wellNAMTT assay100 VP per cell70% cell viablity after 3 daysNoNoNA No responseNANANANA27086483
OV_4610AdenovirusAd5/3-delata 24DNAAdenoviridaeMutation in delta E3 and delta 24 geneYesNoNoVU university medical centre, NetherlandHuman neck and squamous cell carcinoma cell line93VU147T3000 cells per wellNAMTT assay1 VP per cell100% cell viablity after 3 daysNoNoNA No responseNANANANA27086483
OV_4611AdenovirusAd5/3-delata 24DNAAdenoviridaeMutation in delta E3 and delta 24 geneYesNoNoVU university medical centre, NetherlandHuman neck and squamous cell carcinoma cell line93VU147T3000 cells per wellNAMTT assay10 VP per cell50% cell viablity after 3 daysNoNoNA No responseNANANANA27086483
OV_4612AdenovirusAd5/3-delata 24DNAAdenoviridaeMutation in delta E3 and delta 24 geneYesNoNoVU university medical centre, NetherlandHuman neck and squamous cell carcinoma cell line93VU147T3000 cells per wellNAMTT assay100 VP per cell10% cell viablity after 3 daysNoNoNA No responseNANANANA27086483
OV_4613AdenovirusAd5/3-CB016DNAAdenoviridaeMutation in delta E3 geneYesNoNoVU university medical centre, NetherlandHuman neck and squamous cell carcinoma cell line93VU147T3000 cells per wellNAMTT assay1 VP per cell70% cell viablity after 7 daysNoNoNA No responseNANANANA27086483
OV_4614AdenovirusAd5/3-CB016DNAAdenoviridaeMutation in delta E3 geneYesNoNoVU university medical centre, NetherlandHuman neck and squamous cell carcinoma cell line93VU147T3000 cells per wellNAMTT assay10 VP per cell58 cell viablity after 7 daysNoNoNA No responseNANANANA27086483
OV_4615AdenovirusAd5/3-CB016DNAAdenoviridaeMutation in delta E3 geneYesNoNoVU university medical centre, NetherlandHuman neck and squamous cell carcinoma cell line93VU147T3000 cells per wellNAMTT assay100 VP per cell10% cell viablity after 7 daysNoNoNA No responseNANANANA27086483
OV_4616AdenovirusAd5/3-delata 24DNAAdenoviridaeMutation in delta E3 and delta 24 geneYesNoNoVU university medical centre, NetherlandHuman neck and squamous cell carcinoma cell line93VU147T3000 cells per wellNAMTT assay1 VP per cell100% cell killing after 7 daysNoNoNA No responseNANANANA27086483
OV_4617AdenovirusAd5/3-delata 24DNAAdenoviridaeMutation in delta E3 and delta 24 geneYesNoNoVU university medical centre, NetherlandHuman neck and squamous cell carcinoma cell line93VU147T3000 cells per wellNAMTT assay10 VP per cell100% cell killing after 7 daysNoNoNA No responseNANANANA27086483
OV_4618AdenovirusAd5/3-delata 24DNAAdenoviridaeMutation in delta E3 and delta 24 geneYesNoNoVU university medical centre, NetherlandHuman neck and squamous cell carcinoma cell line93VU147T3000 cells per wellNAMTT assay100 VP per cell100% cell killing after 7 daysNoNoNA No responseNANANANA27086483
OV_4619AdenovirusAd5/3-CB016DNAAdenoviridaeMutation in delta E3 geneYesNoNoUniversity of pitsburghHuman neck and squamous cell carcinoma cell lineUPCI SCC 0903000 cells per wellNAMTT assay1 VP per cell100% cell viablity after 3 daysNoNoNA No responseNANANANA27086483
OV_4620AdenovirusAd5/3-CB016DNAAdenoviridaeMutation in delta E3 geneYesNoNoUniversity of pitsburghHuman neck and squamous cell carcinoma cell lineUPCI SCC 0903000 cells per wellNAMTT assay10 VP per cell100% cell viablity after 3 daysNoNoNA No responseNANANANA27086483
OV_4621AdenovirusAd5/3-CB016DNAAdenoviridaeMutation in delta E3 geneYesNoNoUniversity of pitsburghHuman neck and squamous cell carcinoma cell lineUPCI SCC 0903000 cells per wellNAMTT assay100 VP per cell100% cell viablity after 3 daysNoNoNA No responseNANANANA27086483
OV_4622AdenovirusAd5/3-delata 24DNAAdenoviridaeMutation in delta E3 and delta 24 geneYesNoNoUniversity of pitsburghHuman neck and squamous cell carcinoma cell lineUPCI SCC 0903000 cells per wellNAMTT assay1 VP per cell100% cell viablity after 3 daysNoNoNA No responseNANANANA27086483
OV_4623AdenovirusAd5/3-delata 24DNAAdenoviridaeMutation in delta E3 and delta 24 geneYesNoNoUniversity of pitsburghHuman neck and squamous cell carcinoma cell lineUPCI SCC 0903000 cells per wellNAMTT assay10 VP per cell100% cell viablity after 3 daysNoNoNA No responseNANANANA27086483
OV_4624AdenovirusAd5/3-delata 24DNAAdenoviridaeMutation in delta E3 and delta 24 geneYesNoNoUniversity of pitsburghHuman neck and squamous cell carcinoma cell lineUPCI SCC 0903000 cells per wellNAMTT assay100 VP per cell40% cell viablity after 3 daysNoNoNA No responseNANANANA27086483
OV_4625AdenovirusAd5/3-CB016DNAAdenoviridaeMutation in delta E3 geneYesNoNoUniversity of pitsburghHuman neck and squamous cell carcinoma cell lineUPCI SCC 0903000 cells per wellNAMTT assay1 VP per cell80% cell viablity after 7 daysNoNoNA No responseNANANANA27086483
OV_4626AdenovirusAd5/3-CB016DNAAdenoviridaeMutation in delta E3 geneYesNoNoUniversity of pitsburghHuman neck and squamous cell carcinoma cell lineUPCI SCC 0903000 cells per wellNAMTT assay10 VP per cell80% cell viablity after 7 daysNoNoNA No responseNANANANA27086483
OV_4627AdenovirusAd5/3-CB016DNAAdenoviridaeMutation in delta E3 geneYesNoNoUniversity of pitsburghHuman neck and squamous cell carcinoma cell lineUPCI SCC 0903000 cells per wellNAMTT assay100 VP per cell70% cell viablity after 7 daysNoNoNA No responseNANANANA27086483
OV_4628AdenovirusAd5/3-delata 24DNAAdenoviridaeMutation in delta E3 and delta 24 geneYesNoNoUniversity of pitsburghHuman neck and squamous cell carcinoma cell lineUPCI SCC 0903000 cells per wellNAMTT assay1 VP per cell100% cell killing after 7 daysNoNoNA No responseNANANANA27086483
OV_4629AdenovirusAd5/3-delata 24DNAAdenoviridaeMutation in delta E3 and delta 24 geneYesNoNoUniversity of pitsburghHuman neck and squamous cell carcinoma cell lineUPCI SCC 0903000 cells per wellNAMTT assay10 VP per cell100% cell killing after 7 daysNoNoNA No responseNANANANA27086483
OV_4630AdenovirusAd5/3-delata 24DNAAdenoviridaeMutation in delta E3 and delta 24 geneYesNoNoUniversity of pitsburghHuman neck and squamous cell carcinoma cell lineUPCI SCC 0903000 cells per wellNAMTT assay100 VP per cell100% cell killing after 7 daysNoNoNA No responseNANANANA27086483
OV_5626Newcastle disease virusNDV-MK107RNAParamyxoviridaeNoneYesNoNoNAHuman head and neck carcinoma cell lineKB80% confluencyNAMTT assay4 pfu50% of cancer cell death occursNoNoNA No responseNAInduction of apoptosis by virus infectionInduction of IFN-Gamma productionNAUS7470426
OV_5846Newcastle disease virusNDV-PPMK107RNAParamyxoviridaeNoneYesNoNoNAHuman head and neck carcinoma cell lineKB80% confluencyNANA4 pfu50% cancer cell deathNoNoNA No responseNANANANAUS8105578
OV_5847Newcastle disease virusNDV-PPMK107RNAParamyxoviridaeNoneYesNoNoNAHuman head and neck carcinoma cell lineA25380% confluencyNANA2.7 ×10³ pfu50% cancer cell deathNoNoNA No responseNANANANAUS8105578
OV_5848Newcastle disease virusNDV-PPMK107RNAParamyxoviridaeNoneYesNoNoNAHuman head and neck carcinoma cell lineFaDu80% confluencyNANA2.9 ×10³ pfu50% cancer cell deathNoNoNA No responseNANANANAUS8105578
OV_5849Newcastle disease virusNDV-PPMK107RNAParamyxoviridaeNoneYesNoNoNAHuman head and neck carcinoma cell lineHep-280% confluencyNANA1.5 ×10⁴ pfu50% cancer cell deathNoNoNA No responseNANANANAUS8105578
OV_5906Newcastle disease virusNDV-B1RNAParamyxoviridaeNoneYesNoNoATCCHuman neck and head carcinoma cell lineSCC5E+5 pfuNALDH release assay0.1 MOI60% cell killing after 3 daysNoNoNA No responseNANAVirus induced IFN-gamma productionNAUS10035984
OV_5907Newcastle disease virusNDV-B1RNAParamyxoviridaeNoneYesNoNoATCCHuman neck and head carcinoma cell lineSCC5E+5 pfuNALDH release assay0.1 MOINo cell death observed after 3 daysNoNoNA No responseNANAVirus induced IFN-gamma productionNAUS10035984
OV_5908Newcastle disease virusNDV-F3aaRNAParamyxoviridaeVirus expressing NS1 proteinYesNoNoATCCHuman neck and head carcinoma cell lineSCC5E+5 pfuNALDH release assay0.1 MOI100% cell killing observed after 3 daysNoNoNA No responseNANAVirus induced IFN-gamma productionNAUS10035984
OV_5909Newcastle disease virusNDV-F3aaRNAParamyxoviridaeVirus expressing NS1 proteinYesNoNoATCCHuman neck and head carcinoma cell lineSCC5E+5 pfuNALDH release assay0.1 MOI70% cell killing after 3 daysNoNoNA No responseNANAVirus induced IFN-gamma productionNAUS10035984